Publications

In today’s globalized world, companies are expanding beyond their domestic markets at an unprecedented rate. With this growth comes the need to communicate effectively with diverse audiences, and that’s where localization of marketing materials becomes crucial. At Janus Worldwide, we are committed to helping brands adapt their message to resonate across languages and cultures, ensuring that each communication is not just a translation, but a strategic, culturally-aligned tool for success.

In a world where speed and quality of translation is becoming a strategic advantage for businesses, Janus Worldwide reaffirms its reputation as a technology leader in the industry. We are pleased to introduce LEXA, a new cloud-based platform that combines the best solutions from the company and global machine translation providers into a single intelligent system.

As companies expand across borders, localization has become essential – not just an added value. Success now hinges on delivering culturally relevant experiences, not just translated content.

In clinical research, translation is essential. Every patient deserves to fully understand their consent. Unfortunately, many critical documents like informed consent forms and trial instructions are inadequately translated, leading to confusion, misinformed choices, and potential safety risks.

Janus Worldwidelanguage services and translation technology provider has been named by CSA Research as one of the 2025 Global and Regional Market Leaders. The recognition is based on independently verified 2024 revenue data and highlights companies playing a significant role in the global language services and technology market.

In an era of digital transformation, companies seeking sustainable growth are turning to innovative solutions that streamline processes, increase productivity and deliver the highest quality of service. At Janus Worldwide, the answer to these challenges is the Maia project, an internal AI ecosystem that integrates artificial intelligence and key enterprise tools into a single entity.

Modern automated translation technologies are developing rapidly, and two main approaches have come to the fore today: machine translation and translation using artificial intelligence.

Janus successfully uses various automated translation technologies: machine translation (MT) and translation using artificial intelligence. As well as advantages, both technologies have their disadvantages, which are offset by certain customization methods, making each technology suitable for specific translation tasks.

Entering new global markets offers huge growth opportunities for medical device manufacturers. However, success depends on more than technical innovation — it requires clear, accurate, and culturally appropriate communication. High-quality localization is the bridge that connects advanced medical devices with diverse patient groups, healthcare providers, and regulators worldwide.

Medical translations are not just words on paper — they are a lifeline for patients, healthcare professionals, and medical device users worldwide. A single mistranslation can lead to misdiagnosis, ineffective treatment, or even death. Understanding the risks and knowing how to avoid them is critical for any healthcare provider, medical device manufacturer, or pharmaceutical company.